| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |